2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle  
01/11/18ContraFect to Present at Cantor Antibiotics Summit
YONKERS, N.Y., Jan. 11, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that Steven C. Gilman, Ph.D., the Company's Chairman and Chief Executive Officer, will participate in a panel discussion entitled “Novel Ways to Treat and/or Address Infections” at the Cantor Antibiotics Summit on Wednes... 
 Printer Friendly Version
01/03/18ContraFect to Present at 10th Annual Biotech Showcase
YONKERS, N.Y., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that Steven C. Gilman, Ph.D., the Company's Chairman and Chief Executive Officer, will present a corporate overview at the 10th Annual Biotech Showcase on Tuesday, January 9, 2018 at 10:00 AM PT (1:00 PM ET) in San Francisco, CA. The f... 
 Printer Friendly Version
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share

X
| E-mail Alerts E-mail Alerts | IR Contacts Contact IR | Financial Tear Sheet Tear Sheet